certepetide
LSTA1-P02
Phase 2 small_molecule active
Quick answer
certepetide for Cholangiocarcinoma is a Phase 2 program (small_molecule) at LISATA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LISATA THERAPEUTICS, INC.
- Indication
- Cholangiocarcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active